CJC-1295 No DAC + Ipamorelin for Sale: A Complete Guide for Research Buyers

CJC-1295 (no DAC) combined with Ipamorelin has become one of the most frequently ordered peptide blends in growth hormone secretagogue research, valued for the complementary mechanisms of its two components. But when browsing listings for CJC-1295 no DAC Ipamorelin for sale, buyers quickly encounter a fragmented market — ranging from established research chemical suppliers to loosely regulated resellers — where correct labeling, accurate ratios, and verified purity vary enormously from seller to seller.

This guide covers what this peptide blend is, how it’s studied, what to look for in a CJC-1295 Ipamorelin bulk supplier, how pricing works, and how the broader grey market peptide landscape — significantly accelerated by GLP-1 demand — has reshaped sourcing across this category.

This content is intended strictly for informational and research-sourcing purposes. CJC-1295 (no DAC) and Ipamorelin are sold and distributed as research chemicals, not for human consumption, and have no FDA-approved pharmaceutical pathway. Nothing here constitutes medical, dosing, or self-administration guidance.

What Are CJC-1295 (No DAC) and Ipamorelin?

CJC-1295 without DAC — also frequently labeled Mod GRF 1-29 — is a modified fragment of growth hormone-releasing hormone (GHRH). Unlike the DAC (Drug Affinity Complex) version of CJC-1295, which binds to albumin in the bloodstream and extends its half-life to several days, the no-DAC variant has a much shorter half-life, typically measured in minutes. This distinction matters enormously for research design, and mislabeling between the two versions is one of the more common sourcing problems in this category.

Ipamorelin is a selective growth hormone secretagogue that acts on the ghrelin receptor (GHSR), distinguished in the research literature by its relatively selective GH-release profile compared to older-generation secretagogues, with comparatively minimal effect on cortisol and prolactin release.

Because these two peptides act through different but complementary mechanisms — CJC-1295 (no DAC) stimulating the GHRH pathway and Ipamorelin stimulating the ghrelin receptor pathway — they are frequently studied and sold together as a combined research blend, based on published research suggesting a synergistic effect on growth hormone pulsatility when the two pathways are activated together.

In laboratory settings, this blend is studied for applications including:

• Growth hormone pulsatility and combined-pathway secretion research
• Comparative pharmacology between GHRH-pathway and ghrelin-pathway secretagogues
• Structure-stability research specific to the no-DAC variant’s shorter half-life
• Blend ratio and formulation stability studies
• Comparative research against related secretagogue peptides, including Sermorelin and Tesamorelin

Why the Blend Format Adds Sourcing Complexity

Buyers researching CJC-1295 no DAC Ipamorelin for sale should understand that pre-mixed blend vials introduce sourcing considerations beyond what applies to either peptide sold individually.

Ratio accuracy matters. Blend vials are typically sold at specific ratios (commonly 1:1 by weight, such as 5mg/5mg), and verifying that a supplier’s actual product matches its labeled ratio requires independent testing capable of distinguishing and quantifying both peptides in a single sample — a more demanding analytical process than testing a single-peptide vial.

Blend stability differs from single-peptide stability. Combining two peptides in solution can introduce stability considerations that don’t apply to either compound alone, making supplier-specific stability data more important for blends than for individually sourced peptides.

DAC vs. no-DAC labeling errors are common. Because “CJC-1295” without further specification is ambiguous, some listings fail to clearly distinguish which version is included in a blend, or mislabel the DAC version as no-DAC (or vice versa). This is one of the most consistent quality issues reported across the category, making explicit, unambiguous labeling a non-negotiable requirement when evaluating any seller.

What to Look for in a CJC-1295 Ipamorelin Bulk Supplier

Not every seller marketing itself as a CJC-1295 Ipamorelin bulk supplier backs that claim with real evidence. Buyers evaluating options, particularly for larger orders, should assess the following:

Independent, Batch-Specific Certificates of Analysis

A credible supplier provides COAs from accredited third-party labs, tied to the specific batch shipped, confirming both peptides’ identity and ratio within the blend. The COA should report:

• HPLC purity percentage for each peptide component
• Mass spectrometry confirmation of molecular identity for both CJC-1295 (no DAC) and Ipamorelin
• Confirmed blend ratio matching the labeled specification
• Batch/lot number and synthesis date

Explicit DAC vs. No-DAC Labeling

A reliable supplier states unambiguously, in both product listings and on shipped packaging, that the CJC-1295 component is the no-DAC (Mod GRF 1-29) variant rather than the extended-half-life DAC version.

Manufacturing Transparency

Ask where and how each peptide is synthesized, and whether the blending process itself is documented and quality-controlled. Suppliers unwilling to answer basic manufacturing and blending questions are a consistent warning sign.

Consistent Research-Use Labeling

Legitimate suppliers label the blend clearly as “for research use only, not for human or veterinary use” across packaging, invoices, and product listings alike. A supplier pairing this labeling with off-label dosing protocols elsewhere on their site is signaling a mismatch between how the product is labeled and how it’s actually marketed.

Proper Cold-Chain Handling

This blend is a lyophilized peptide combination sensitive to heat, light, and moisture. Bulk shipments should include desiccant packaging and, depending on climate and transit time, cold-pack shipping.

Understanding Pricing for This Blend

Price for CJC-1295 (no DAC) + Ipamorelin blends varies based on several factors worth understanding before comparing quotes:

Purity threshold for both components. Look for ≥98% purity confirmed independently for each peptide in the blend, not just an aggregate purity claim. Some sellers quote purity for only one component or use vague blended purity figures that obscure individual peptide quality.

Ratio and total peptide content. Blends are typically priced based on total combined peptide mass (e.g., a 5mg/5mg vial contains 10mg total peptide), so compare pricing on a like-for-like basis rather than assuming vial count alone reflects total peptide content.

Order volume. Per-unit price drops meaningfully at scale, but small-vial pricing isn’t a reliable predictor of bulk rates — always request a dedicated quote for larger orders.

Synthesis and blending capacity. Suppliers who synthesize and blend in-house generally offer more stable pricing and better ratio consistency than resellers repackaging product sourced from elsewhere.

Category-wide demand pressure. Broader demand growth across the research peptide sector — driven substantially by the GLP-1 peptide boom — has pushed manufacturing capacity and reagent costs up across the industry generally, with knock-on effects on pricing for adjacent compounds, including GH secretagogue blends like this one, despite the mechanisms involved being entirely unrelated to GLP-1 pathways.

Unusually low pricing relative to the category average, particularly for a two-component blend claiming high purity on both peptides, is worth investigating rather than treating as a bargain.

Where to Buy CJC-1295 Ipamorelin: Comparing Your Options

When researching where to buy CJC-1295 Ipamorelin, buyers generally encounter a few distinct tiers of seller:

Established research chemical suppliers operate with visible transparency — published, batch-specific COAs confirming both peptide identities and ratio, clear DAC vs. no-DAC labeling, and responsive technical support for questions about synthesis and blend stability.

Marketplace resellers sit between the manufacturer and buyer, often at a higher per-milligram cost, with less direct traceability back to the original manufacturing and blending process.

Unverified or grey market sellers operate with minimal transparency, frequently through social media, forums, or marketplaces with limited seller accountability — the tier where ratio accuracy, DAC/no-DAC mislabeling, and general quality control issues are most commonly reported.

The safest approach for buyers considering this blend at any meaningful volume is working directly with a manufacturer or an established distributor with a documented, verifiable manufacturing and blending relationship, rather than defaulting to the cheapest available listing.

What Sets a Reliable Peptide Blend Supplier Apart

Because blended products carry more sourcing complexity than single-peptide vials, a genuine peptide blend supplier should offer a few things beyond what a single-compound seller needs to provide:

Component-specific testing. Independent confirmation of both peptides’ identity and purity individually, not just an aggregate claim about the finished blend.

Documented blending process. Transparency about how the two peptides are combined, at what stage, and under what quality controls — including how ratio consistency is verified across a production batch.

Consistent labeling across all materials. Product listings, invoices, and shipped packaging should all specify the same information: exact peptide identities (including explicit no-DAC labeling), ratio, and total peptide content per vial.

What to Expect From a CJC-1295 Ipamorelin Wholesale Supplier

Buyers purchasing at scale — labs, CROs, or resellers — should expect additional considerations from a genuine CJC-1295 Ipamorelin wholesale supplier:

Clear tiered pricing with defined price breaks at specific quantity thresholds, rather than opaque one-off negotiated deals.

Batch consistency guarantees, particularly important for blends given the added variable of ratio accuracy across a production run.

Reliable supply continuity, since stockouts mid-research-program can be more disruptive for a specific blend formulation than for a widely available single peptide with more substitutable suppliers.

Institutional-friendly documentation, including SDS sheets and business registration confirmation, which academic and CRO buyers in particular typically require.

Any Reliable Peptide Supplier Should Meet a Consistent Baseline

Regardless of the specific compound or blend, a trustworthy peptide supplier should meet the same baseline standard: independent third-party testing tied to specific batches, transparent manufacturing and blending information, accurate rather than inflated marketing claims, and honest research-use-only labeling. Applying this consistent standard, whether sourcing a single peptide or a combined formulation like CJC-1295 (no DAC) + Ipamorelin, helps buyers avoid the lower-quality end of the market.

The Grey Market Peptide Landscape and This Blend

The research-chemical market for CJC-1295 (no DAC) + Ipamorelin exists alongside a substantial grey market — a space where compounds labeled “research use only” are frequently purchased by individuals for personal use rather than genuine laboratory research. This pattern spans much of the peptide category broadly, and GH secretagogue blends like this one, given their popularity in bodybuilding and anti-aging circles, are particularly exposed to this dynamic.

The labeling-versus-use gap. “Research use only” remains the accurate and, in most jurisdictions, legally required label for compounds sold outside pharmaceutical channels. But because enforcement of actual end-use is difficult, a meaningful share of buyers in this space purchase research-labeled peptide blends for personal use rather than laboratory research — a pattern common across the category rather than specific to any one supplier.

GLP-1 as the market’s accelerant. The explosive growth in demand for GLP-1 receptor agonists has reshaped the broader peptide manufacturing and distribution ecosystem. More manufacturing capacity has come online, more sellers have entered the market, and logistics networks supporting peptide distribution have matured considerably. This blend, while mechanistically unrelated to GLP-1 agonists, is frequently sold through overlapping supplier networks and has been affected by these broader market currents, both in pricing and in the sheer number of new sellers entering the space.

Quality variability is especially pronounced for blends. Independent testing of grey market peptide products has repeatedly found discrepancies between labeled and actual content across various compounds — and blended products add the additional risk of incorrect ratios or DAC/no-DAC mislabeling on top of standard purity concerns.

Regulatory scrutiny continues to increase. As demand for peptides sold through informal channels has grown, regulators in multiple countries have increased attention on compounding pharmacies, importers, and online sellers — a trend spanning GLP-1 peptides and adjacent research compounds alike.

For a CJC-1295 Ipamorelin wholesale supplier operating transparently, the practical differentiator is straightforward: clear labeling (including explicit no-DAC specification), verifiable third-party testing for both components, and honest research-use-only positioning separate a credible business from the grey market noise surrounding the category.

Storage and Handling

Proper storage protects both product integrity and research reproducibility.

• Lyophilized powder: Store at -20°C for long-term stability; short-term refrigeration (2–8°C) is generally acceptable for a period of weeks.
• Reconstituted blend solution: Stability drops considerably after reconstitution, and combined formulations may have different stability characteristics than either peptide alone. Store refrigerated and use within the supplier’s stated stability window for the specific blend.
• Light sensitivity: Store in opaque or amber containers, away from direct light.
• Avoid freeze-thaw cycling: Aliquot reconstituted product before freezing to prevent repeated freeze-thaw degradation.
• Shipping conditions: Shipments should include desiccant packaging and, depending on climate, appropriate cold-chain measures to preserve stability during transit.

Always request the supplier’s specific stability data for the blend itself, rather than assuming it matches the stability profile of either peptide sourced individually.

How to Evaluate Real Customer Reviews

Rather than presenting invented testimonials, it’s more useful to explain how buyers can genuinely assess supplier reputation, since fabricated or incentivized reviews are common throughout the research peptide category.

Look for reviews on independent platforms — peptide research forums, industry-specific communities, or third-party review sites — rather than testimonials hosted exclusively on a supplier’s own website, which are easy to fabricate or selectively curate.

Prioritize specificity over enthusiasm. Reviews referencing specific batch testing results, ratio verification, communication quality, or packaging and shipping conditions carry far more weight than generic praise with no substance behind it.

Watch for suspicious clustering. A sudden spike of similar-sounding, glowing reviews posted within a short window often signals incentivized or purchased feedback rather than organic customer experience.

Cross-reference reputation across multiple sources. Reputation signals are far more reliable in aggregate — checking a supplier across several independent platforms — than relying on any single review source alone.

Frequently Asked Questions

What is CJC-1295 no DAC Ipamorelin used for in research? This blend is primarily studied for combined growth hormone pathway research, examining the synergistic effect of GHRH-pathway activation (via CJC-1295 no DAC) alongside ghrelin-receptor activation (via Ipamorelin) on growth hormone pulsatility.

What’s the difference between CJC-1295 with DAC and without DAC? CJC-1295 with DAC has an extended half-life of several days due to albumin binding, while the no-DAC version (also called Mod GRF 1-29) has a much shorter half-life. These are distinct compounds, and confirming which version is included in any blend is essential before comparing suppliers or research literature.

Is this peptide blend legal to purchase? CJC-1295 (no DAC) and Ipamorelin, sold and labeled as research chemicals, are legal to purchase in many jurisdictions, though legal status varies by country and by intended use. Buyers should confirm applicable regulations before ordering.

What purity level should I look for? Most research applications call for ≥98% purity for each individual peptide component, verified through third-party HPLC and mass spectrometry testing. Always request a batch-specific COA confirming both components rather than an aggregate purity figure.

How is bulk pricing typically structured for this blend? Bulk pricing is usually tiered by total peptide quantity, with per-milligram cost decreasing at defined thresholds. Always confirm whether pricing reflects total combined peptide mass or individual component mass before comparing suppliers.

How do I verify a CJC-1295 Ipamorelin bulk supplier is legitimate? Request third-party COAs confirming both peptide identities and the blend ratio, ask about synthesis and blending processes, confirm explicit no-DAC labeling, and look for a verifiable business history with references from institutional buyers.

Why does pricing for this blend vary so much between sellers? Pricing differences reflect purity verification standards for each component, ratio accuracy, synthesis and blending capacity, and broader demand pressure across the peptide sector, including spillover effects from GLP-1-driven market growth.

Is grey market CJC-1295 Ipamorelin the same quality as verified suppliers? Not reliably. Grey market channels generally lack consistent independent testing for both blend components, and ratio inaccuracies or DAC/no-DAC mislabeling are more commonly reported in these channels compared to suppliers who provide verifiable, batch-specific third-party COAs.

What documentation should accompany a bulk order? At minimum: a certificate of analysis confirming both peptide identities and ratio, batch/lot number, synthesis date, and clear research-use-only labeling with explicit no-DAC specification. Institutional buyers may also want a safety data sheet and business registration confirmation.

How should this reconstituted blend be stored? Refrigerated (2–8°C), used within the supplier’s recommended stability window for the specific blend, and protected from light and repeated freeze-thaw cycles.

Choosing the Right Partner

The research peptide market has grown quickly, and the number of sellers marketing CJC-1295 no DAC Ipamorelin for sale has grown right alongside it — not all to the same standard, and blended products carry additional sourcing risk beyond single-peptide purchases. The compounds driving the sector’s overall growth, particularly GLP-1 peptides, have brought increased attention, expanded manufacturing capacity, and unfortunately more inconsistency into the broader grey market peptide space that this blend sits within.

For research institutions and serious buyers, the fundamentals remain unchanged: verify purity and ratio independently for both components, confirm clear and consistent research-use-only labeling with explicit no-DAC specification, and favor a CJC-1295 Ipamorelin wholesale supplier who answers manufacturing and blending questions directly rather than deflecting them. A transparent peptide supplier is a far better long-term partner than one simply offering the lowest number on a quote for anyone researching where to buy CJC-1295 Ipamorelin.